- Report
- May 2024
- 182 Pages
Global
From €3434EUR$3,825USD£2,925GBP
€4040EUR$4,500USD£3,441GBP
- Report
- February 2024
- 120 Pages
Global
From €4265EUR$4,750USD£3,632GBP
- Report
- September 2023
- 140 Pages
Global
From €3231EUR$3,599USD£2,752GBP
- Report
- October 2024
- 96 Pages
Global
From €3500EUR$4,176USD£3,085GBP
The Cancer Profiling market within the Diagnostics industry is focused on the development of tests that can detect the presence of cancer in a patient. These tests are used to identify the type of cancer, its stage, and the best treatment options. Cancer profiling tests are used to detect genetic mutations, which can help doctors determine the best course of treatment for a patient. These tests are also used to monitor the progress of a patient's cancer treatment.
The Cancer Profiling market is highly competitive, with many companies offering a variety of tests. Some of the major players in the market include Illumina, Thermo Fisher Scientific, QIAGEN, Agilent Technologies, and Roche. Show Less Read more
